Sponsor

Synvista Therapeutics, Inc

Clinical research sponsor

Published trials12
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

12 shown
Safety & Efficacy of ALT-711 (Alagebrium) in Chronic Heart FailureNCT00739687 · lead sponsor · 2008-08-01
TERMINATED
Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)NCT00662116 · lead sponsor · 2008-03-01
TERMINATED
Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and MicroalbuminuriaNCT00557518 · lead sponsor · 2007-11-01
TERMINATED
The BENEFICIAL Study: Evaluating the Efficacy and Safety of Alagebrium (ALT-711) in Patients With Chronic Heart FailureNCT00516646 · lead sponsor · 2007-08-01
COMPLETED
Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery DiseaseNCT00491543 · lead sponsor · 2007-06-01
COMPLETED
A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI)NCT00320502 · lead sponsor · 2006-05-01
COMPLETED
The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic HypertensionNCT00302250 · lead sponsor · 2006-02-01
COMPLETED
Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA)NCT00089713 · lead sponsor · 2004-03-01
TERMINATED
STRETCH Study: Effect of Distensibility on Endothelial-Dependent Vasoreactivity in Patients With ISHNCT00277875 · lead sponsor · 2004-02-01
COMPLETED
The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart FailureNCT00043836 · lead sponsor · 2002-07-01
COMPLETED
The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)NCT00045981 · lead sponsor · 2001-10-01
COMPLETED
The SILVER Study: Systolic Hypertension Interaction With Left Ventricular RemodelingNCT00045994 · lead sponsor · 2001-08-01
COMPLETED

Sponsor roles

lead sponsor12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.